Effectiveness of Non-nucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Women Previously Exposed to a Single Intrapartum Dose of Nevirapine: A Multi-country, Prospective Cohort Study

BACKGROUND: Intrapartum and neonatal single-dose nevirapine (NVP) reduces the risk of mother-to-child HIV transmission but also induces viral resistance to non-nucleoside reverse transcriptase inhibitor (NNRTI) drugs. This drug resistance largely fades over time. We hypothesized that women with a pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Stringer, Jeffrey S. A., McConnell, Michelle S., Kiarie, James, Bolu, Omotayo, Anekthananon, Thanomsak, Jariyasethpong, Tavatchai, Potter, Dara, Mutsotso, Winnie, Borkowf, Craig B., Mbori-Ngacha, Dorothy, Muiruri, Peter, Ong'ech, John Odero, Zulu, Isaac, Njobvu, Lungowe, Jetsawang, Bongkoch, Pathak, Sonal, Bulterys, Marc, Shaffer, Nathan, Weidle, Paul J.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821896/
https://www.ncbi.nlm.nih.gov/pubmed/20169113
http://dx.doi.org/10.1371/journal.pmed.1000233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821896/
https://www.ncbi.nlm.nih.gov/pubmed/20169113
http://dx.doi.org/10.1371/journal.pmed.1000233

Ejemplares similares